Towards interpretable drug interaction prediction <i>via</i> dual-stage attention and Bayesian calibration with active learning

We present DABI-DDI, an integrated feature extraction framework that successfully addresses key challenges in DDIs prediction through three major innovations: Temporal pattern recognition, reducing false positives, and biological interpretability. Most importantly, the framework demonstrates strong clinical applicability by efficiently identifying high-risk drug combinations while providing mechanistic insights through enzyme-transporter pathway analysis. This approach bridges the gap between computational prediction and clinical understanding, offering a promising tool for safer drug combination therapy.

Authors

Institutions

Publication Details

Journal
PeerJ Computer Science
Published
2025-04-22
DOI
https://doi.org/10.7717/peerj-cs.2847
Citations
3
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
4.51
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Towards interpretable drug interaction prediction via dual-stage attention and Bayesian calibration with active learning

Rongpei Li, Guihua Jia, Deyue An, Heqi Sun et al.
3 citations
PeerJ Computer Science
Computational Drug Discovery Methods
4.51
article

Towards interpretable drug interaction prediction via dual-stage attention and Bayesian calibration with active learning

Rongpei Li, Guihua Jia, Deyue An, Heqi Sun, Yitian Fang, Yajing Yuan, Aman Chandra Kaushik, Dong‐Qing Wei, Shenggeng Lin, Xueying Mao, Xiaotong Song, Chen Zhang, Jianwei Zhao, Jiayi Li, Lyubin Hu, Yufang Zhang
article en
3 citations

Abstract

We present DABI-DDI, an integrated feature extraction framework that successfully addresses key challenges in DDIs prediction through three major innovations: Temporal pattern recognition, reducing false positives, and biological interpretability. Most importantly, the framework demonstrates strong clinical applicability by efficiently identifying high-risk drug combinations while providing mechanistic insights through enzyme-transporter pathway analysis. This approach bridges the gap between computational prediction and clinical understanding, offering a promising tool for safer drug combination therapy.

PeerJ Computer ScienceVol. 11
Shanghai Jiao Tong University (CN), Qihe People's Hospital (CN), Peng Cheng Laboratory (CN)
Openalex Percentile: Top 6%
Computational Drug Discovery Methods
4.51
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Towards interpretable drug interaction prediction <i>via</i> dual-stage attention and Bayesian calibration with active learning — Rongpei Li, Guihua Jia, et al. · PeerJ Computer Science (2025) | TGRS Research Map | TGRS